Last checked at 3 Nov 2020 15:53
DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares
DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat22
AGL Share
Trades100
AGL
Live RNS
AGL Share
Charts
AGL Level 2
Console
AGL Live
Share Price
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
Angle Information
Share Price Information for Angle (AGL)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
14.75
Bid:
14.50
Ask:
15.00
Change:
-0.75 (-4.84%)
Spread:
0.50 (3.448%)
Open:
16.00
High:
16.00
Low:
14.75
Prev. Close:
15.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.29 Oct 2020 14:46
UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale
UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale
Read more27 Oct 2020 19:06
UPDATE: Angle Successfully Raises GBP20 Million In Placing
UPDATE: Angle Successfully Raises GBP20 Million In Placing
Read more27 Oct 2020 12:37
IN BRIEF: Angle To Raise GBP20 Million To Fund Operations
IN BRIEF: Angle To Raise GBP20 Million To Fund Operations
Read more22 Oct 2020 16:01
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more20 Oct 2020 14:18
IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer
IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer
Read more20 Oct 2020 08:58
FDA accepts Angle's review submission for Parsortix PC1
(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.
Read more28 Sep 2020 19:33
IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix
IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix
Read more20 Aug 2020 16:00
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more14 Aug 2020 12:41
Angle's Parsortix Able To Predict Patients' Response To Treatment
Angle's Parsortix Able To Predict Patients' Response To Treatment
Read more20 Jul 2020 20:03
IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix
IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix
Read more20 Jul 2020 10:16
Angle's 'Parsortix' advantageous in breast cancer in new research
(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.
Read more25 Jun 2020 12:22
Angle Progresses On Parsortix And De Novo Clearance From US Regulator
Angle Progresses On Parsortix And De Novo Clearance From US Regulator
Read more18 Jun 2020 16:05
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more10 Jun 2020 16:41
IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board
IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board
Read more